The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Leukotriene D4
Hierarchy: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriene D4 2 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriene D4 2 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriene D4 2 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriene D4 2 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriene D4 2 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriene D4 2 coordinate conceptsX |
Broader terms: | |
Annotation: | /biosyn /physiol permitted; DF: note short X ref
X |
History note: | SRS-A (1982-1993)X |
historyNote*: | 94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93
X |
onlineNote*: | use SRS-A to search LEUKOTRIENE D4 & LEUKOTRIENES D 1983-93
X |
publicMeSHNote*: | 94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93
X |
Scope note: | One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990)
X |
activeMeSHYear*: | |
dateCreated*: | 1993-06-04X |
dateEstablished*: | 1994-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | ssbX |
recordOriginator*: | TPWX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Leukotrieeni D4 (fi) XLeukotrien D4 (sv) LTD4 (en, replaced) Leukotriene D-4 (en, replaced) Leukotriene D (en, replaced) |
Share: |
Loading results...